Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Nectar Lifescience LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532649NSE Symbol: NECLIFEP/E(TTM):0
ISIN Demat:INE023H01027Div & Yield %:0EPS(TTM):0
Book Value(Rs):31.9661998Market Cap ( Cr.):314.86Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 1908.401925.831746.561924.921762.272639.28
Excise Duty238.43241.75222.89256.69220.45276.48
Net Sales1669.971684.081523.671668.231541.822362.80
Other Income 4.9914.5843.1811.323.794.32
Stock Adjustments -117.2940.2141.64-14.97-102.805.25
Total Income1557.671738.871608.491664.581442.812372.37
EXPENDITURE :      
Raw Materials 1250.721242.451200.841207.321052.821862.83
Power & Fuel Cost104.16129.52127.39101.4184.6392.72
Employee Cost 93.6181.7175.1471.9170.5578.19
Other Manufacturing Expenses 59.2555.3044.8845.0944.1646.39
Selling and Administration Expenses 71.1761.3861.0166.8272.0066.18
Miscellaneous Expenses 3.332.371.321.9031.043.72
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1582.241572.731510.591494.441355.192150.04
Operating Profit-24.57166.1397.91170.1387.63222.33
Interest 74.5887.1479.4878.81112.03125.82
Gross Profit-99.1578.9918.4391.32-24.4096.51
Depreciation62.3960.7259.1256.9760.2560.77
Profit Before Tax-161.5418.27-40.6934.35-84.6535.74
Tax-47.8513.27-18.249.03-11.501.66
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.000.000.000.000.004.02
Reported Net Profit-113.685.00-22.4625.32-73.1530.06
Extraordinary Items 0.020.1840.519.41-25.410.22
Adjusted Net Profit-113.704.82-62.9715.91-47.7429.84
Adjst. below Net Profit 0.54-0.340.190.810.001.26
P & L Balance brought forward703.93699.27721.54695.41766.26739.31
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.000.001.121.35
P & L Balance carried down590.79703.93699.27721.54691.99769.28
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.005.00
Earnings Per Share-Unit Curr-5.070.22-1.001.13-3.261.34
Earnings Per Share(Adj)-Unit Curr-5.070.22-1.001.13-3.261.34
Book Value-Unit Curr42.6347.6847.4748.4647.3050.59